Another panelist — Dr. Warris Bokhari, CEO of Claimable — agreed that it should be a qualified human making the decision on ...
Sickle cell disease and beta thalassemia are the startup’s lead indications. While gene therapies are available for both ...
News emerging during the annual HLTH conference, including ones from Abridge, reflects the growing use of AI in clinical ...
MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed a wide range of healthcare startups ...
Hone Health, a longevity platform, announced on Wednesday that it has raised $228 million in financing to support its expansion. The direct-to-consumer company offers access to biomarker testing, ...
Accelerated FDA approval of Johnson & Johnson’s Rybrevant Faspro covers advanced cases of head and neck cancer. The ...
Health systems are jumping to integrate AI into clinicians' everyday tools. When those platforms also offer the medical ...
By applying proven and enforceable guardrails, coupled with smart financial incentives, we can ensure AI elevates medical ...
Typically, software placed on the market will undergo changes and updates after its initial release. In the case of ...
Oyster Therapeutics’ lead program penetrates the brain to degrade pathological tau associated with Alzheimer’s disease. Eli ...
Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of ...
The Series B round was led by Drive Capital, with participation from Sanofi Ventures, HealthX Ventures, Alumni Ventures, ...